Omeros Corporation

OMER Healthcare Biotechnology

In the quarter to June 2026, revenue grew 35.5%, EPS grew 141.9%, free cash flow grew 118.7% and total debt fell 42.0%, each against the same quarter a year earlier.

16.20 2.59 −13.78%
Market cap
$1.4B
P/E
9.5×
Fwd P/E
2.1×
Dividend yield
—
F-score
2/9
Altman Z
−6.82
Beneish M
−0.06
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
215.67 134.12 217.90 443.24 247.96 151.29 103.75 89.87 108.37 60.26
Total non-current assets
109.97 142.96 160.37 147.73 171.31 29.76 33.22 6.07 7.96 7.02
Total Assets
325.63 277.08 378.27 590.97 419.27 181.04 136.97 95.94 116.33 67.28
Total current liabilities
78.06 79.53 53.32 136.38 51.79 36.74 55.46 37.36 26.31 16.07
Total non-current liabilities
368.80 380.16 349.94 368.90 343.70 265.06 190.53 158.74 92.84 88.65
Total liabilities
446.86 459.69 403.25 505.29 395.49 301.79 245.99 196.09 119.14 104.73
Common Equity (Total)
(121.23) (182.61) (24.98) 85.68 23.78 (120.75) (109.02) (100.16) (2.81) (37.45)
Shareholders Equity (Total)
(121.23) (182.61) (24.98) 85.68 23.78 (120.75) (109.02) (100.16) (2.81) (37.45)
Total Debt
208.54 187.58 213.16 315.29 318.71 240.07 161.72 149.87 83.80 79.71

Show all line items

In millions of $ except per-share values · columns are period end dates